Direct Meds vs K Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Direct Meds
Best for listed for transparent disclosure — see FDA warning and BBB complaint pattern before consideringStarting at $249/mo
K Health
Best for users who want general primary care with GLP-1 prescribing as one available option, not a single-condition weight-loss funnelStarting at $300/mo
Side-by-Side Comparison
| Feature | Direct Meds | K Health |
|---|---|---|
| Overall Score | 5.4/10 | ✓6.6/10 |
| Starting Price | ✓$249/mo | $300/mo |
| Editorial Rating | 2.7 ★ /5 | ✓3.3 ★ /5 |
| Features | ✓5 features | 4 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | 1 warning | ✓None |
Pros & Cons
Direct Meds
Pros
- ✓Both semaglutide and tirzepatide available in injection and sublingual formats
- ✓All-inclusive pricing with medication, consultations, supplies, and 1–2 day temperature-controlled shipping
- ✓LegitScript certification confirmed (verified December 2025)
- ✓Named 503A pharmacy partners: CraftedRx (Warrenton, MO) and ChemistryRx (Folcroft, PA)
Cons
- ✗FDA warning letter September 9, 2025 for misleading marketing of compounded GLP-1s as equivalent to FDA-approved drugs — compliance status post-warning not publicly documented
- ✗Extensive Better Business Bureau complaint pattern (rating 1.12/5 across 226 reviews as of April 2026) documenting a hidden 3-month commitment trap: multiple users report being charged $940+ for a 3-month supply when they believed they were purchasing 1 month. Direct Meds disputes the characterization but the complaint volume is material
- ✗Katalys program name 'Direct Meds GLP-1 Offers Top Funnels' and $280 CPA payout indicate aggressive performance-marketing optimization, which can correlate with conversion-first UX patterns
- ✗Rating discrepancy: Trustpilot 4.6/5 from 7,500+ reviews vs. BBB 1.12/5 from 226 reviews — suggests either review-solicitation bias or genuine unresolved customer experience issues
- ✗Not available in Mississippi, Louisiana, or California
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Incorporated May 2024 — less than 2 years of operational history
- ✗Auto-renewal continues until manual email cancellation; BBB complaints report retention-department friction and hold times exceeding 15 minutes
K Health
Pros
- ✓Established US telehealth with health-system integrations (Cedars-Sinai, Hartford HealthCare, Hackensack Meridian)
- ✓AI intake reduces upfront friction for users who don't want to sit through a long questionnaire before seeing a clinician
- ✓Primary-care relationship rather than a single-condition funnel — useful for users who want one provider managing multiple conditions
Cons
- ✗Not a GLP-1 specialty platform — weight management is ancillary to primary care, and GLP-1 prescribing is clinician-discretionary at the visit level
- ✗Pricing for GLP-1 specifically is not displayed publicly — needs direct confirmation from K Health support before placing readers
- ✗States served list and pharmacy partners are not publicly enumerated
Our Verdict
K Health edges out Direct Meds with a higher overall score of 6.6/10 and is particularly strong for users who want general primary care with GLP-1 prescribing as one available option, not a single-condition weight-loss funnel. Direct Meds remains a solid alternative, especially if you're looking for listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.